Manufacturer record
Eastern Healthcare: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
4 batches manufactured by Eastern Healthcare (Uttarakhand) were declared Not of Standard Quality between November 2025 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: DRT25284, Paracetamol, Phenylephrine Hydrochloride, Chlorpheniramine Maleate and Caffeine Tablets (exp Aug 2027). RDTL, Bellary, Karnataka (state lab) found it not of standard quality: Description. Listed in the September 2026 alert.
Records by type
4 records linked to Eastern Healthcare in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Paracetamol, Phenylephrine Hydrochloride, Chlorpheniramine Maleate and Caffeine Tablets | Batch DRT25284Mfg Sep 2025 · Exp Aug 2027 | DescriptionDescription | RDTL, Bellary, KarnatakaState lab | Sep 2026 |
| Paracetamol Tablets IP 650 mg | Batch DRT23139Mfg Nov 2023 · Exp Oct 2026 | Dissolution testDissolution | SDT&RL, BhubaneswarState lab | Mar 2026 |
| Amitriptyline Tablets IP | Batch DRT24032Mfg Feb 2024 · Exp Jan 2026 | The sample does not conform to I.P. in respect of the test Assay performed.Assay | West BengalState lab | Jan 2026 |
| Amitriptyline Tablets IP | Batch DRT25096Mfg Apr 2025 · Exp Mar 2027 | The sample does not conform to claim as per IP 2022 in respect to the Test of DescriptionDescription | RDTL,ChandigarhCDSCO lab | Nov 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.